Tsart MCL 25 Tablet

Tsart MCL 25 Tablet is a combination of three medicines: Cilnidipine, metoprolol and telmisartan. They work by different mechanisms to provide better control of blood pressure when single or dual therapy is not effective. Cilnidipine is a calcium channel blocker (CCB) and telmisartan is an angiotensin receptor blocker (ARB). They work by widening and relaxing the blood vessels, thereby lowering blood pressure. Metoprolol is a beta blocker that works specifically on the heart to slow down the heart rate.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tsart MCL 25 Tablet is to be taken with food.

Pregnancy Unsafe

Tsart MCL 25 Tablet is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.

Breastfeeding Ask your doctor

No information is available on the use of Tsart MCL 25 Tablet during lactation. Please consult your doctor.

Driving Caution

Tsart MCL 25 Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.

Kidney Ask your doctor

There is limited information available on the use of Tsart MCL 25 Tablet in patients with kidney disease. Please consult your doctor.

Liver Caution

Tsart MCL 25 Tablet should be used with caution in patients with liver disease. Dose adjustment of Tsart MCL 25 Tablet may be needed. Please consult your doctor. Use of Tsart MCL 25 Tablet is not recommended in patients with severe liver disease.